Elia Group SA/NV (ELI)
Euronext Brussels · Belgium · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 125.10 |
|---|---|
| 52-week range | 99.05 – 143.10 |
| Return, 1 month / 3 months | +3.9% / −10.5% |
| Return, 1 year / 3 years | +18.0% / +60.6% |
| Trend | Below its 200-day average |
| RSI (14) | 62 |
| Volatility (1 year) | 24.6% |
| Worst drawdown (1 year) | -18.4% |
| Average daily value traded | 12.68M EUR |
| Dividend yield | 1.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Elia Group operates electricity transmission networks, moving high-voltage power across Belgium and Germany. Its Belgian arm runs the national grid, while its German subsidiary FiftyHertz does the same in that country. The company connects generators, including wind farms offshore, to the grid and delivers power to distribution operators and large industrial users. It also manages cross-border interconnections that link national networks. Elia Group is based in Brussels and serves utilities, industry and grid operators across its home markets.
The shares are listed on the Euronext Brussels in Belgium under the code ELI, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Elia Group SA/NV (ELI) trades on the Euronext Brussels in Belgium. It last closed at EUR 125.10 on 22 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 46 of 111 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 18.0% and over the last three months it fell 10.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Brussels
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 54 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -2.8% | ||
| From 52-week high | -11.5% | ||
| Momentum | 46 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -10.5% | ||
| 6-month return | -8.8% | ||
| 12-month return, skipping the last month | 13.6% | ||
| Stability (higher is calmer) | 65 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 24.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.4% | ||
| Liquidity | 95 · Strong | Trades actively. | |
| Average daily value traded | 12.68M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 39 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.6% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +3.1% |
|---|---|
| 1 month | +3.9% |
| 3 months | −10.5% |
| 6 months | −8.8% |
| 1 year | +18.0% |
| 3 years | +60.6% |
| 5 years | +48.3% |
Signals
| 50-day / 200-day average | 121.41 / 128.71 |
|---|---|
| Golden / death cross (60 days) | Death, 21 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.66 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 May 2026 | EUR 2.0500 |
| 29 May 2025 | EUR 2.0500 |
| 19 Mar 2025 | EUR 1.9420 |
| 30 May 2024 | EUR 1.8852 |
| 30 May 2023 | EUR 1.8094 |
| 30 May 2022 | EUR 1.6578 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Brussels; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.